Cognitive disorders and tau-protein expression among retired aluminum smelting workers

Journal of Occupational and Environmental Medicine

Volumn 56, Issue 2, 2014, Pages 155-160

  Lu, Xiaoting ^a   Liang, Ruifeng ^a   Jia, Zhijian ^a   Wang, Hao ^a   Pan, Baolong ^a   Zhang, Qinli ^a   Niu, Qiao ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALUMINUM; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHINA; COHORT STUDIES; HUMANS; LYMPHOCYTES; METALLURGY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; TAU PROTEINS;

EID: 84894050146     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000100     Document Type: Article

References (38)

1. Kumar V, Gill KD. Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol. 2009;83:965-978.
2. Longstreth WT Jr, Rosenstock L, Heyer NJ. Potroom palsy? Neurologic disorder in three aluminum smelter workers. Arch Intern Med. 1985;145:1972-1975. (Pubitemid 16198392)
3. Hosovski E, Mastelica Z, Sunderic D, Radulovic D. Mental abilities of workers exposed to aluminium. Med Lav. 1990;81:119-123. (Pubitemid 20250979)
4. White DM, Longstreth WT Jr, Rosenstock L, et al. Neurologic syndrome in 25 workers from an aluminum smelting plant. Arch Intern Med. 1992;152:1443-1448.
5. Soni MG, White SM, Flamm WG, Burdock GA. Safety evaluation of dietary aluminum. Regul Toxicol Pharmacol. 2001;33:66-79. (Pubitemid 32242948)
6. Polizzi S, Pira E, Ferrara M, et al. Neurotoxic effects of aluminium among foundry workers and Alzheimer's disease. Neurotoxicology. 2002;23:761-774. (Pubitemid 36004742)
7. Buchta M, Kiesswetter E, Otto A, et al. Longitudinal study examining the neurotoxicity of occupational exposure to aluminium-containing welding fumes. Int Arch Occup Environ Health. 2003;76:539-548. (Pubitemid 37254238)
8. Giorgianni C, Faranda M, Brecciaroli R, et al. Cognitive disorders among welders exposed to aluminum. G Ital Med Lav Ergon. 2003;25(suppl):102-103. (Pubitemid 38198403)
9. Riihimaki V, Aitio A. Occupational exposure to aluminum and its biomonitoring in perspective. Crit Rev Toxicol. 2012;42:827-853.
10. Meyer-Baron M, Schaper M, Knapp G, Van Thriel C. Occupational aluminum exposure: evidence in support of its neurobehavioral impact. Neurotoxicology. 2007;28:1068-1078. (Pubitemid 350026593)
11. Pavlovic DM, Pavlovic AM. Mild cognitive impairment. Srp Arh Celok Lek. 2009;137:434-439.
12. Thomann PA, Kaiser E, Schonknecht P, et al. Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease. J Psychiatry Neurosci. 2009;34:136-142.
13. Mitchell AJ. CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies. J Neurol Neurosurg Psychiatry. 2009;80:966-975.
14. Mandelkow EM, Schweers O, Drewes G, et al. Structure, microtubule interactions, and phosphorylation of tau protein. Ann N Y Acad Sci. 1996;777:96-106. (Pubitemid 26149176)
15. Polydoro M, Acker CM, Duff K, Castillo PE, Davies P. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci. 2009;29:10741-10749.
16. Ravaglia S, Bini P, Sinforiani E, et al. Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia. Neurol Sci. 2008;29:417-423.
17. Savory J, Huang Y, Herman MM, Reyes MR, Wills MR. Tau immunoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits. Brain Res. 1995;669:325-329.
18. Madhav TR, Vatsala S, Ramakrishna T, Ramesh J, Easwaran KR. Preservation of native conformation during aluminium-induced aggregation of tau protein. Neuroreport. 1996;7:1072-1076. (Pubitemid 26194483)
19. Botta C, Iarmarcovai G, Chaspoul F, et al. Assessment of occupational exposure to welding fumes by inductively coupled plasma-mass spectroscopy and by the alkaline Comet assay. Environ Mol Mutagen. 2006;47:284-295.
20. Pozueta A, Rodriguez-Rodriguez E, Vazquez-Higuera JL, et al. Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test. BMC Neurol. 2011;11:78.
21. Guerrero-Berroa E, Luo X, Schmeidler J, et al. The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly. Int J Geriatr Psychiatry. 2009;24:1429-1437.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Cummings JL. Mini-Mental State Examination. Norms, normals, and numbers.JAMA. 1993;269:2420-2421. (Pubitemid 23129386)
24. Yue M, Fainsinger RL, Bruera E. Cognitive impairment in a patient with a normal Mini-Mental State Examination (MMSE). J Pain Symptom Manage. 1994;9:51-53. (Pubitemid 24061827)
25. Meyer J, Xu G, Thornby J, Chowdhury M, Quach M. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci. 2002;201:19-25. (Pubitemid 34876900)
26. Blandini F, Sinforiani E, Pacchetti C, et al. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology. 2006;66:529-534. (Pubitemid 43739882)
27. Kiesswetter E, Schaper M, Buchta M, et al. Longitudinal study on potential neurotoxic effects of aluminium: I. Assessment of exposure and neurobehavioural performance of Al welders in the train and truck construction industry over 4 years. Int Arch Occup Environ Health. 2007;81:41-67. (Pubitemid 47288771)
28. Bondy SC. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology. 2010;31:575-581.
29. Rondeau V, Jacqmin-Gadda H, Commenges D, Dartigues JF. Re: aluminum in drinking water and cognitive decline in elderly subjects: the Paquid cohort. Am J Epidemiol. 2001;154:288-290. (Pubitemid 32701167)
30. Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol. 2009;169:489-496.
31. Fei M, Qu YC, Wang T, et al. Prevalence and distribution of cognitive impairment no dementia (CIND) among the aged population and the analysis of socio-demographic characteristics: the communitybased cross-sectional study. Alzheimer Dis Assoc Disord. 2009;23:130-138.
32. Crapper DR, Krishnan SS, Dalton AJ. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science. 1973;180:511-513.
33. Klatzo I, Wisniewski H, Streicher E. Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J Neuropathol Exp Neurol. 1965;24:187-199.
34. Brys M, Pirraglia E, Rich K, et al. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging. 2009;30:682-690.
35. Bramblett GT, Goedert M, Jakes R, et al. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 1993;10:1089-1099. (Pubitemid 23194399)
36. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 1993;11:153-163. (Pubitemid 23222542)
37. Kvetnoy IM, Hernandez-Yago J, Kvetnaia TV, et al. Tau-protein expression in human blood lymphocytes: a promising marker and suitable sample for lifetime diagnosis of Alzheimer's disease. Neuro Endocrinol Lett. 2000;21:313-318. (Pubitemid 30642711)
38. Armentero MT, Sinforiani E, Ghezzi C, et al. Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease. Neurobiol Aging. 2011;32:2142-2151.